Codeine

Category
alkaloid
Routes
Oral (PO)
Half-Life (t½)
PO: 3h
Formula
C18H21NO3
Molecular Weight
299.36 g/mol
PubChem CID
5284371
Aliases
Methylmorphine

Pharmacological Mechanism

Methylated morphine prodrug — analgesic effect requires hepatic CYP2D6 demethylation to morphine, the active µ-opioid receptor agonist (~10% of dose). CYP2D6 ultrarapid metabolizers risk respiratory depression; poor metabolizers get little analgesia.

Half-Life & Elimination Curve (PO: 3h)

100%50%25%12.5%0%0h0×t½3h1×t½6h2×t½9h3×t½12h4×t½15h5×t½0×t½ (0h): 100% remaining (~42.9 µg/L)1×t½ (3h): 50% remaining (~21.4 µg/L)2×t½ (6h): 25% remaining (~10.7 µg/L)3×t½ (9h): 12.5% remaining (~5.36 µg/L)4×t½ (12h): 6.3% remaining (~2.68 µg/L)5×t½ (15h): 3.1% remaining (~1.34 µg/L)
Plasma (PO)t½ Decay (3h)
  • 0×t½0h100% (42.9 µg/L)
  • 1×t½3h50% (21.4 µg/L)
  • 2×t½6h25% (10.7 µg/L)
  • 3×t½9h12.5% (5.36 µg/L)
  • 4×t½12h6.3% (2.68 µg/L)
  • 5×t½15h3.1% (1.34 µg/L)
Elimination t½3h (PO)
Rate Constant (ke)0.231 h⁻¹
Time to Peak (Tmax)1.54h
Est. Peak (Cmax)42.9 µg/L
Clearance (CL)56.6 L/h
97% Washout (5×t½)15h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References